Table 3.18.
Key considerations in dental management in asthma (see text)
Management modifications* | Comments/possible complications | |
---|---|---|
Risk assessment | 2 |
|
Pain and anxiety control | ||
– Local anaesthesia | 1 | Avoid epinephrine (sulphites) |
– Conscious sedation | 1 | Avoid sedatives |
– General anaesthesia | 3–5 | Pulmonary complications; cardiac failure |
Patient access and positioning | ||
– Access to dental office | 0 | |
– Timing of treatment | 1 | Late morning |
– Patient positioning | 1 | |
Treatment modification | ||
– Oral surgery | 1/4 | Consider INR |
– Implantology | 1/4 | |
– Conservative/Endodontics | 1 | |
– Fixed prosthetics | 1 | Materials selection |
– Removable prosthetics | 1 | Materials selection |
– Non-surgical periodontology | 1 | |
– Surgical periodontology | 1/4 | |
Hazardous and contraindicated drugs | 2 | Avoid aspirin, NSAIDs, sulphites, penicillin, and other erythromycin drugs interacting with theophylline |
0 = No special considerations. 1 = Caution advised. 2 = Specialised medical advice recommended in some cases. 3 = Specialised medical advice mandatory. 4 = Only to be performed in hospital environment. 5 = Should be avoided.